金宝通(00320.HK)拟斥100万美元认购30万股幻月股份
格隆汇 12 月 15日丨金宝通(00320.HK)宣布,于2020年12月15日,公司的全资附属公司认购方与幻月及现有股东订立认购协议,据此,认购方同意认购,而幻月同意配发及发行30万股认购股份,代价为100万美元。紧随完成后,认购方将持有幻月经扩大股本(经认购事项扩大)约13.04%。
据悉,幻月为根据香港法律注册成立的有限公司,幻月集团主要从事于香港、中国及马来西亚提供消费电子类的通讯及无线产品。
公告称,透过与幻月订立认购协议,公司旨在通过日后合作设计及生产产品及解决方案,发挥幻月于建造及设计射频通信产品的专长。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.